Integrins as Target First Phase III Trial Launches, but Questions RemainCarter, AndreaJournal of the National Cancer Institute 102(10):p 675-677, May 19, 2010. | DOI: 10.1093/jnci/djq186Copyright © Copyright Oxford University Press 2010.
